PLoS ONE (Jan 2012)

Lacrimal proline rich 4 (LPRR4) protein in the tear fluid is a potential biomarker of dry eye syndrome.

  • Saijyothi Venkata Aluru,
  • Shweta Agarwal,
  • Bhaskar Srinivasan,
  • Geetha Krishnan Iyer,
  • Sivakumar M Rajappa,
  • Utpal Tatu,
  • Prema Padmanabhan,
  • Nirmala Subramanian,
  • Angayarkanni Narayanasamy

DOI
https://doi.org/10.1371/journal.pone.0051979
Journal volume & issue
Vol. 7, no. 12
p. e51979

Abstract

Read online

Dry eye syndrome (DES) is a complex, multifactorial, immune-associated disorder of the tear and ocular surface. DES with a high prevalence world over needs identification of potential biomarkers so as to understand not only the disease mechanism but also to identify drug targets. In this study we looked for differentially expressed proteins in tear samples of DES to arrive at characteristic biomarkers. As part of a prospective case-control study, tear specimen were collected using Schirmer strips from 129 dry eye cases and 73 age matched controls. 2D electrophoresis (2DE) and Differential gel electrophoresis (DIGE) was done to identify differentially expressed proteins. One of the differentially expressed protein in DES is lacrimal proline rich 4 protein (LPRR4). LPRR4 protein expression was quantified by enzyme immune sorbent assay (ELISA). LPRR4 was down regulated significantly in all types of dry eye cases, correlating with the disease severity as measured by clinical investigations. Further characterization of the protein is required to assess its therapeutic potential in DES.